BioRegs Pilot is an AI-native platform designed to assist small and medium-sized biotech and medical device companies navigate the labyrinthine world of regulatory compliance (FDA, EMA, etc.). It automates the generation of compliant documentation, identifies critical gaps in trial data, and provides dynamic, personalized guidance on submission pathways, dramatically accelerating time-to-market for innovations.
The increasing complexity of global biomedical regulations combined with breakthroughs in multimodal AI (understanding scientific text, clinical data, and images) allows for automated interpretation and application of regulatory guidelines. This democratizes compliance for smaller players who can't afford large legal teams.
Founders, R&D leads, and regulatory affairs specialists in biotech and medical device startups and SMBs. They'll pay to reduce regulatory overhead, avoid costly delays, and increase their chances of market approval.
Subscription tiers based on the stage of development (e.g., pre-clinical, clinical, submission), number of active projects, and access to specialized regulatory modules (e.g., GDPR compliance for patient data, specific country regulations).